REM behaviour disorder and neurodegenerative diseases

Stefano Zanigni, Giovanna Calandra-Buonaura, Daniela Grimaldi, Pietro Cortelli

Research output: Contribution to journalArticle

Abstract

Rapid-eye movement (REM) sleep behaviour disorder (RBD) is an REM sleep parasomnia characterized by enactment of dream content during REM sleep associated with loss of muscle atonia. RBD can be either idiopathic or secondary to drugs or other diseases. The best recognized association is with neurodegenerative diseases, namely alpha-synucleinopathies. RBD may represent the first feature of neurodegeneration and can be considered an early marker of these disorders. This review describes the main clinical, pathogenetic, and therapeutic features of RBD, pointing to its association with neurodegenerative diseases and emphasizing the clinical and prognostic implications.

Original languageEnglish
JournalSleep Medicine
Volume12
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Dec 2011

Fingerprint

REM Sleep Behavior Disorder
Ocular Motility Disorders
REM Sleep
Mental Disorders
Neurodegenerative Diseases
REM Sleep Parasomnias
Sleep
Muscles
Pharmaceutical Preparations

Keywords

  • Dementia
  • Neurodegenerative
  • Parasomnias
  • Parkinson
  • Parkinsonism
  • REM behaviour disorder
  • REM sleep

ASJC Scopus subject areas

  • Medicine(all)

Cite this

REM behaviour disorder and neurodegenerative diseases. / Zanigni, Stefano; Calandra-Buonaura, Giovanna; Grimaldi, Daniela; Cortelli, Pietro.

In: Sleep Medicine, Vol. 12, No. SUPPL. 2, 12.2011.

Research output: Contribution to journalArticle

@article{ff1f041602e744c592338d8593c87729,
title = "REM behaviour disorder and neurodegenerative diseases",
abstract = "Rapid-eye movement (REM) sleep behaviour disorder (RBD) is an REM sleep parasomnia characterized by enactment of dream content during REM sleep associated with loss of muscle atonia. RBD can be either idiopathic or secondary to drugs or other diseases. The best recognized association is with neurodegenerative diseases, namely alpha-synucleinopathies. RBD may represent the first feature of neurodegeneration and can be considered an early marker of these disorders. This review describes the main clinical, pathogenetic, and therapeutic features of RBD, pointing to its association with neurodegenerative diseases and emphasizing the clinical and prognostic implications.",
keywords = "Dementia, Neurodegenerative, Parasomnias, Parkinson, Parkinsonism, REM behaviour disorder, REM sleep",
author = "Stefano Zanigni and Giovanna Calandra-Buonaura and Daniela Grimaldi and Pietro Cortelli",
year = "2011",
month = "12",
doi = "10.1016/j.sleep.2011.10.012",
language = "English",
volume = "12",
journal = "Sleep Medicine",
issn = "1389-9457",
publisher = "Elsevier",
number = "SUPPL. 2",

}

TY - JOUR

T1 - REM behaviour disorder and neurodegenerative diseases

AU - Zanigni, Stefano

AU - Calandra-Buonaura, Giovanna

AU - Grimaldi, Daniela

AU - Cortelli, Pietro

PY - 2011/12

Y1 - 2011/12

N2 - Rapid-eye movement (REM) sleep behaviour disorder (RBD) is an REM sleep parasomnia characterized by enactment of dream content during REM sleep associated with loss of muscle atonia. RBD can be either idiopathic or secondary to drugs or other diseases. The best recognized association is with neurodegenerative diseases, namely alpha-synucleinopathies. RBD may represent the first feature of neurodegeneration and can be considered an early marker of these disorders. This review describes the main clinical, pathogenetic, and therapeutic features of RBD, pointing to its association with neurodegenerative diseases and emphasizing the clinical and prognostic implications.

AB - Rapid-eye movement (REM) sleep behaviour disorder (RBD) is an REM sleep parasomnia characterized by enactment of dream content during REM sleep associated with loss of muscle atonia. RBD can be either idiopathic or secondary to drugs or other diseases. The best recognized association is with neurodegenerative diseases, namely alpha-synucleinopathies. RBD may represent the first feature of neurodegeneration and can be considered an early marker of these disorders. This review describes the main clinical, pathogenetic, and therapeutic features of RBD, pointing to its association with neurodegenerative diseases and emphasizing the clinical and prognostic implications.

KW - Dementia

KW - Neurodegenerative

KW - Parasomnias

KW - Parkinson

KW - Parkinsonism

KW - REM behaviour disorder

KW - REM sleep

UR - http://www.scopus.com/inward/record.url?scp=82855162673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82855162673&partnerID=8YFLogxK

U2 - 10.1016/j.sleep.2011.10.012

DO - 10.1016/j.sleep.2011.10.012

M3 - Article

C2 - 22136901

AN - SCOPUS:82855162673

VL - 12

JO - Sleep Medicine

JF - Sleep Medicine

SN - 1389-9457

IS - SUPPL. 2

ER -